Marcos Milla

Marcos Milla is a Venture Partner with Samsara BioCapital. Previously, Marcos was the Head of Synthorx, a Sanofi company, and was the Chief Scientific Officer of Synthorx until its acquisition by Sanofi. Marcos has over 25 years of biopharmaceutical development experience across the areas of autoimmunity and inflammation, immuno-oncology, and neurosciences and pain, having held industry positions at Adaptive Biotechnologies, Janssen R&D, Roche, and GlaxoSmithKline, and a faculty appointment at the Perelman School of Medicine of the University of Pennsylvania. Marcos is currently on the faculty of Skaags School of Pharmacy and Pharmaceutical Sciences of University of California – San Diego.